Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01022216 · ClinicalTrials.gov registry record · Phase 2
Efficacy Study of a Bioelectric Dressing Used With Negative Pressure Wound Therapy to Treat Diabetic and Pressure Ulcers
A Phase 2 study of Wound Healing, sponsored by Vomaris Innovations.
- Completed
- Registry status
- Phase 2
- Development phase
- 30
- Enrollment target
- 1
- Study location
NCT01022216: Completed Phase 2 study of Wound Healing, sponsored by Vomaris Innovations.
NCT01022216 is a Phase 2 study of Wound Healing that has completed, run by Vomaris Innovations. The registered enrollment target is 30 participants, below the 55-participant average among 11 other Wound Healing trials with a reported enrollment target (45% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01022216, a Phase 2 study of Wound Healing, has completed, sponsored by Vomaris Innovations.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 30 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this study is to determine whether a bioelectric wound dressing, used in conjunction with Negative Pressure Wound Therapy (NPWT), is effective in the treatment of diabetic and pressure ulcers of the foot.
Conditions Studied
Interventions
- DEVICE Procellera™ Wound Dressing with V.A.C.® Therapy
- DEVICE V.A.C.® Therapy
Study Locations (1)
New York
- Wyckoff Heights Medical Center - Brooklyn
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 30 participants |
| Start Date | 2009-08 |
| Est. Completion | 2011-11 |
| Phase | Phase 2 |
What the finished NCT01022216 record still lists
NCT01022216 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 30 participants, a relatively small participant target, below the 55-participant average among 11 other Wound Healing trials with a reported enrollment target (45% lower).
The record links to 1 condition, with Wound Healing appearing as the primary indexed condition, and to 2 interventions - of which Procellera™ Wound Dressing with V.A.C.® Therapy is the first listed.
NCT01022216 reports a single indexed study location in New York.
Frequently Asked Questions
What is clinical trial NCT01022216 about?
NCT01022216 is a clinical study titled "Efficacy Study of a Bioelectric Dressing Used With Negative Pressure Wound Therapy to Treat Diabetic and Pressure Ulcers". The purpose of this study is to determine whether a bioelectric wound dressing, used in conjunction with Negative Pressure Wound Therapy (NPWT), is effective in the treatment of diabetic and pressure ulcers of the foot.
What is the current status of trial NCT01022216?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 30 participants. The study started on 2009-08. Estimated completion is 2011-11.
What conditions does trial NCT01022216 study?
This clinical trial studies the following conditions: Wound Healing.
What interventions are being tested in trial NCT01022216?
The interventions under investigation include: Procellera™ Wound Dressing with V.A.C.® Therapy (DEVICE), V.A.C.® Therapy (DEVICE).
Who is sponsoring clinical trial NCT01022216?
This trial is sponsored by Vomaris Innovations, which has 4 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01022216 being conducted?
This trial has 1 study location across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Wound Healing
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT01022216's enrollment target sits among peer trials
30 7th of 11 higher than 4 of 11 other Wound Healing trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Wound Healing trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Evaluating rhPDGF-BB-Enhanced Wound Matrix for Head and Neck Reconstruction
RECRUITING · Phase 2
-
Dose Regimen Study of SLI-F06 in Healthy Volunteers
RECRUITING · Phase 2
-
Silk Bioprotein as a Wound Dressing for Double-Incision Mastectomy
RECRUITING · NA
-
Determinants of Bone Dimensional Changes After Extraction and Alveolar Ridge Preservation
RECRUITING
-
Hydrocolloid Dressings for Oculofacial Plastic and Reconstructive Wound Healing
RECRUITING · NA
-
NPWT Reduction Mammaplasty
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00977977 · 30 participants · Phase 2
Rituximab Plus Cyclosporine in Idiopathic Membranous Nephropathy
- NCT01459107 · 30 participants · Phase 2
Human Upper Extremity Allotransplantation
- NCT01666080 · 30 participants · NA
Second or Greater Allogeneic Hematopoietic Stem Cell Transplant Using Reduced Intensity Conditioning (RIC)
- NCT01720836 · 30 participants · Phase 1
Study of the Immune Response of MUC1 (Mucin1) Peptide Vaccine for Non-small Cell Lung Cancer
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia